Computational Tool for Drug Designing
Abstract
Drug designing is very time and resource consuming process, requiring optimization of several parameters. Computer-aided drug designing plays a vital role in drug discovery and development and has become an important tool in the pharmaceutical industry. Here, the two basic methods of computer-aided drug designing, viz., structure-based computer-aided drug designing and ligand-based computer-aided drug designing technology are discussed. Keywords: drug, drug designing, QSAR, structure-based, virtual screeningReferences
Mandal S., Moudgil M., Mandal S.K.
Rational drug design, Eur J
Pharmacol. 2009; 625(1–3): 90–100p.
Sliwoski G., Kothiwale S., Meiler J., et
al. Computational methods in drug
discovery, Pharmacol Rev. 2013;
(1): 334–95p.
Kalyaanamoorthy S., Chen Y.P.
Structure-based drug design to
augment hit discovery, Drug Discov
Today. 2011; 16: 831–9p.
Jorgensen W.L. Drug discovery: pulled
from a protein’s embrace, Nature.
; 466: 42–3p.
Irwin J.J., Shoichet B.K. ZINC is a
free database of commerciallyavailable
compounds for virtual
screening. ZINC contains over 8
million purchasable compounds in
ready-to-dock, 3D formats, J Chem Inf
Model. 2005; 45: 177–82p.
Haraki K.S., Sheridan R.P.,
Venkataraghavan R., et al. Looking for
pharmacophores in 3-D databases:
does conformational searching
improve the yield of actives?
Tetrahedron Comput Methodol. 1990;
: 565–73p.
Blaney J.M., Dixon J.S. A good ligand
is bard to find: automated docking
methods, Perspect Drug Discov Des.
; 1: 301–19p.
Jones G., Willett P., Glen R.C., et al.
Development and validation of a
genetic algorithm for flexible docking,
J Mol Biol. 1997; 267: 727–48p.
Wang R., Liu L., Lai L., et al. SCORE:
a new empirical method for estimating
the binding affinity of a protein-ligand
complex, J Mol Model. 1998; 4: 379–
p.
Walters W.P., Stahl M.T., Murcko
M.A. Virtual screening: an overview,
Drug Discov Today. 1998; 3: 160–78p.
Leach A.R., Hann M.M. The in silica
world of virtual libraries, Drug Discov
Today. 2000; 5: 326–36p.
Lewis R.A., Pickett S.D., Clark D.E.
Computer-aided molecular diversity
analysis and combinatorial library
design, Rev Comput Chem. 2000; 16:
–51p.
Vyas V., Jain A., Jain A., et al. Virtual
screening: a fast tool for drug design.
Sci Pharm. 2008; 76: 333–60p.
Abagyan R., Totrov M. Highthroughput
docking for lead
generation, Curr Opin Chem Biol.
; 4: 375–82p.
Lipinski C.A., Lombardo F., Dominy
B.W., et al. Experimental and
computational approaches to estimate
solubility and permeability in drug
discovery and development settings,
Adv Drug Del Rev. 1997; 23: 3–25p.
Ghose A.K., Viswanadhan V.N.,
Wendoloski J.J. A knowledge-based
approach in designing combinatorial or
medicinal chemistry libraries for drug
discovery, J Combin Chem. 1999; 1:
–68p.
Johnson M.A., Maggiora G.M.
Concepts and Applications of
Molecular Similarity. New York:
Wiley; 1990.
